Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

Go to page: 1 2 [Full Text] NextPage
Displaying Investigations 1 to 100 of 196 found
From 17 References


Asmann et al 2011, Nucleic Acids Res
  Adenocarcinoma Breast
ARID1A/WDTC1
t(1;1)(p36;p36)

Babiceanu et al 2016, Nucleic Acids Res
  Nonneoplastic epithelial disorder/lesion Uterus, corpus
CTNNBIP1/CLSTN1
t(1;1)(p36;p36)
  Nonneoplastic epithelial disorder/lesion Skin
CTNNBIP1/CLSTN1
t(1;1)(p36;p36)
  Nonneoplastic epithelial disorder/lesion Adrenal
CTNNBIP1/CLSTN1
t(1;1)(p36;p36)
  Nonneoplastic epithelial disorder/lesion Oesophagus
CTNNBIP1/CLSTN1
t(1;1)(p36;p36)

Frattini et al 2013, Nat Genet
  Astrocytoma, grade III-IV/Glioblastoma Brain
CAPZB/UBR4
t(1;1)(p36;p36)
  Astrocytoma, grade III-IV/Glioblastoma Brain
EPHB2/CPSF3L
t(1;1)(p36;p36)
  Astrocytoma, grade III-IV/Glioblastoma Brain
MTOR/CAMTA1
t(1;1)(p36;p36)

Hu et al 2018, Nucleic Acids Res
  Squamous cell carcinoma Lung
ACAP3/DVL1
t(1;1)(p36;p36)
  Malignant epithelial tumor, special type Uterus, corpus
ACOT7/DNAJC11
t(1;1)(p36;p36)
  Adenocarcinoma Oesophagus
ACOT7/PLEKHG5
t(1;1)(p36;p36)
  Squamous cell carcinoma Uterus, cervix
ACOT7/MIB2
t(1;1)(p36;p36)
  Mesenchymal tumor, NOS Unknown site
ALPL/EIF4G3
t(1;1)(p36;p36)
  Adenocarcinoma Breast
ARHGEF19/ANO7L1
t(1;1)(p36;p36)
  Adenocarcinoma Breast
ARID1A/DHDDS
t(1;1)(p36;p36)
  Adenocarcinoma Liver
ARID1A/PRKCZ
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
ARID1A/RPS6KA1
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
CAPZB/APITD1
t(1;1)(p36;p36)
  Malignant epithelial tumor, special type Uterus, corpus
CAPZB/TMCO4
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
CASZ1/SPSB1
t(1;1)(p36;p36)
  Astrocytoma, grade I-II Brain
CASZ1/AGTRAP
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
CASZ1/MASP2
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
CASZ1/EXOSC10
t(1;1)(p36;p36)
  Adenocarcinoma Pancreas
CASZ1/SLC9A1
t(1;1)(p36;p36)
  Adenocarcinoma Large intestine
CCNL2/MRPL20
t(1;1)(p36;p36)
  Adenocarcinoma Lung
CEP85/FAM110D
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
CLIC4/RCAN3
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
CLIC4/NCMAP
t(1;1)(p36;p36)
  Adenocarcinoma Prostate
CLSTN1/IFFO2
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
CPSF3L/GNB1
t(1;1)(p36;p36)
  Squamous cell carcinoma Lung
CTNNBIP1/UBE4B
t(1;1)(p36;p36)
  Mesenchymal tumor, NOS Unknown site
DVL1/PLCH2
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
ECE1/WNT4
t(1;1)(p36;p36)
  Adenocarcinoma Lung
EFHD2/FHAD1
t(1;1)(p36;p36)
  Adenocarcinoma Large intestine
EIF4G3/CFAP74
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
EPHA2/FBXO42
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
FBLIM1/CELA2B
t(1;1)(p36;p36)
  Malignant epithelial tumor, special type Uterus, corpus
FBXO42/SPATA21
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
GALE/PITHD1
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
GNB1/CFAP74
t(1;1)(p36;p36)
  Squamous cell carcinoma Lung
GNB1/CALML6
t(1;1)(p36;p36)
  Adenocarcinoma Liver
GPATCH3/KDF1
t(1;1)(p36;p36)
  Transitional cell carcinoma Bladder
H6PD/CA6
t(1;1)(p36;p36)
  Squamous cell carcinoma Lung
HNRNPR/E2F2
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
HP1BP3/EIF4G3
t(1;1)(p36;p36)
  Germ cell tumor, NOS Testis
ICMT/ACOT7
t(1;1)(p36;p36)
  Adenocarcinoma Breast
IFNLR1/STPG1
t(1;1)(p36;p36)
  Transitional cell carcinoma Bladder
IL22RA1/STPG1
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
KDM1A/EPHB2
t(1;1)(p36;p36)
  Adenocarcinoma Large intestine
KIF1B/RERE
t(1;1)(p36;p36)
  Transitional cell carcinoma Bladder
LDLRAP1/TMEM57
t(1;1)(p36;p36)
  Germ cell tumor, NOS Testis
LIN28A/CD52
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
LUZP1/IFNLR1
t(1;1)(p36;p36)
  Transitional cell carcinoma Bladder
MAN1C1/TMEM50A
t(1;1)(p36;p36)
  Adenocarcinoma Liver
MASP2/EXOSC10
t(1;1)(p36;p36)
  Malignant epithelial tumor, special type Uterus, corpus
MTOR/MAD2L2
t(1;1)(p36;p36)
  Squamous cell carcinoma Lung
MXRA8/CDK11A
t(1;1)(p36;p36)
  Adenocarcinoma Oesophagus
NBL1/MINOS1
t(1;1)(p36;p36)
  Squamous cell carcinoma Uterus, cervix
NIPAL3/GRHL3
t(1;1)(p36;p36)
  Transitional cell carcinoma Bladder
NOC2L/TCEB3
t(1;1)(p36;p36)
  Mesenchymal tumor, NOS Unknown site
NOC2L/LRRC38
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
NOL9/ESPN
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
PEX14/EPHA2
t(1;1)(p36;p36)
  Squamous cell carcinoma Uterus, cervix
PLEKHN1/KLHL17
t(1;1)(p36;p36)
  Benign epithelial tumor, special type Thyroid
PRDM2/LRRC38
t(1;1)(p36;p36)
  Adenocarcinoma Breast
PRKCZ/GABRD
t(1;1)(p36;p36)
  Adenocarcinoma Breast
RAP1GAP/CELA3B
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
RERE/SLC2A7
t(1;1)(p36;p36)
  Adenocarcinoma Lung
RERE/ENO1
t(1;1)(p36;p36)
  Mesenchymal tumor, NOS Unknown site
RPL22/PRDM16
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
RPL22/ACOT7
t(1;1)(p36;p36)
  Mesenchymal tumor, NOS Unknown site
SKI/CAPZB
t(1;1)(p36;p36)
  Adenocarcinoma Kidney
SPEN/CTRC
t(1;1)(p36;p36)
  Astrocytoma, grade I-II Brain
SPEN/TTC34
t(1;1)(p36;p36)
  Adenocarcinoma Prostate
SPEN/FHAD1
t(1;1)(p36;p36)
  Squamous cell carcinoma Uterus, cervix
SPEN/PLEKHM2
t(1;1)(p36;p36)
  Squamous cell carcinoma Uterus, cervix
SPEN/DNAJC16
t(1;1)(p36;p36)
  Adenocarcinoma Liver
SYF2/RHD
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
SYF2/USP48
t(1;1)(p36;p36)
  Squamous cell carcinoma Uterus, cervix
TCEA3/ASAP3
t(1;1)(p36;p36)
  Squamous cell carcinoma Lung
UBE4B/PDPN
t(1;1)(p36;p36)
  Squamous cell carcinoma Lung
UBE4B/PLEKHG5
t(1;1)(p36;p36)
  Mesenchymal tumor, NOS Unknown site
UBR4/C1QC
t(1;1)(p36;p36)
  Squamous cell carcinoma Lung
USP48/MAN1C1
t(1;1)(p36;p36)
  Squamous cell carcinoma Lung
USP48/SEPN1
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
USP48/HSPG2
t(1;1)(p36;p36)
  Squamous cell carcinoma Uterus, cervix
WASF2/ACOT7
t(1;1)(p36;p36)
  Astrocytoma, grade I-II Brain
WASF2/TMEM222
t(1;1)(p36;p36)
  Malignant melanoma Skin
VPS13D/TNFRSF1B
t(1;1)(p36;p36)
  Adenocarcinoma Prostate
VPS13D/TNFRSF8
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
VPS13D/MFN2
t(1;1)(p36;p36)
  Adenocarcinoma Stomach
ZBTB17/MTOR
t(1;1)(p36;p36)
  Malignant epithelial tumor, special type Uterus, corpus
ZBTB17/FBXO42
t(1;1)(p36;p36)
  Benign epithelial tumor, special type Thyroid
ZBTB40/TMEM57
t(1;1)(p36;p36)
  Adenocarcinoma Uterus, corpus
ZBTB40/NBPF3
t(1;1)(p36;p36)

Iwakawa et al 2013, Genes Chromosomes Cancer
  Undifferentiated carcinoma, small cell Lung
RERE/SLC2A5
t(1;1)(p36;p36)

Kalyana-Sundaram et al 2012, Neoplasia
  Adenocarcinoma Breast
GPATCH3/CAMTA1
t(1;1)(p36;p36)
  Adenocarcinoma Breast
MINOS1/RCC2
t(1;1)(p36;p36)

Kekeeva et al 2016, Cancer Lett
  Transitional cell carcinoma Bladder
CASZ1/DFFA
t(1;1)(p36;p36)

Kloosterman et al 2017, Cancer Res
  Adenocarcinoma Large intestine
THAP3/TCEA3
t(1;1)(p36;p36)

NextPage